Fig. 3
From: Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets
The prognostic value of KPNA2 mRNA expression using Kaplan–Meier plotter (KMPlot) across all breast cancers (A-D) and intrinsic molecular subtypes (E-T). Corresponding HRs for OS, RFS, DMFS), and PPS survival endpoints are presented for each breast cancer subtype. HR: Hazard ratio, BC: Breast Cancer, OS: Overall Survival, RFS: Relapse-free Survival, DMFS: Disease-Metastatic Free Progression Survival, and PPS: Post-Progression Survival